Edition:
United States

Jiangxi Boya Bio-Pharmaceutical Co Ltd (300294.SZ)

300294.SZ on Shenzhen Stock Exchange

61.26CNY
25 May 2017
Change (% chg)

¥-0.07 (-0.11%)
Prev Close
¥61.33
Open
¥61.66
Day's High
¥62.54
Day's Low
¥60.91
Volume
1,307,522
Avg. Vol
1,644,678
52-wk High
¥74.24
52-wk Low
¥48.38

Latest Key Developments (Source: Significant Developments)

Jiangxi Boya Bio-Pharmaceutical's shareholder cuts stake in the company
Monday, 15 May 2017 06:26am EDT 

May 15 (Reuters) - Jiangxi Boya Bio-Pharmaceutical Co Ltd <300294.SZ>:Says shareholder has unloaded 1.6 percent stake in the company on may 15, taking its holdings to 1.7 percent after transaction from 3.3 percent.  Full Article

Jiangxi Boya Bio-Pharmaceutical plans share private placement, share trade to resume
Monday, 17 Apr 2017 05:55am EDT 

April 17 (Reuters) - Jiangxi Boya Bio-Pharmaceutical Co Ltd <300294.SZ>:Says it plans to raise up to 1.0 billion yuan ($145.24 million) in share private placement to fund project.Says share trade to resume on April 18.  Full Article

Jiangxi Boya Bio-pharmaceutical receives patents and patent of utility model certificate
Friday, 7 Apr 2017 03:35am EDT 

Jiangxi Boya Bio-pharmaceutical Co Ltd <300294.SZ> : Says it received patents for preparation procedure of fibrinogen extraction(No.ZL 2014 1 0524351.2) and preparation procedure of human hepatitis b immunoglobulin(No.ZL 2014 1 0442079.3) .It received patent of utility model certificate for blood products related device(No.ZL 2016 2 0652566.7).  Full Article

Jiangxi Boya Bio-pharmaceutical proposes FY 2016 dividend payment
Thursday, 23 Mar 2017 05:32am EDT 

Jiangxi Boya Bio-pharmaceutical Co., Ltd.<300294.SZ>:Says the co proposed to pay a cash dividend of 1 yuan for every 10 shares and use additional paid-in capital to distribute 5 new shares for every 10 shares, as the dividend payment plan for FY 2016.  Full Article

Jiangxi Boya Bio-Pharmaceutial sees Q1 FY 2017 net profit up 60 pct to 90 pct
Thursday, 23 Mar 2017 03:11am EDT 

Jiangxi Boya Bio-Pharmaceutial Co Ltd <300294.SZ> : Sees Q1 FY 2017 net profit to increase by 60 percent to 90 percent, or to be 61.7 million yuan to 73.2 million yuan . Says Q1 FY 2016 net profit was 38.5 million yuan .The reason for the forecast is blood products business growth, investment income and tax refund.  Full Article

Jiangxi Boya Bio-Pharmaceutical names Liao Xixin as chairman
Thursday, 9 Mar 2017 03:00am EST 

Jiangxi Boya Bio-Pharmaceutical Co Ltd <300294.SZ>:Says it names Liao Xixin as chairman.  Full Article

Jiangxi Boya Bio-pharmaceutical's shareholder to unload shares in next 6 months
Wednesday, 8 Mar 2017 04:52am EST 

Jiangxi Boya Bio-pharmaceutical Co Ltd <300294.SZ> :Says its shareholder it plans to unload up to 10.6 million shares, equivalent to a 3.97 percent stake, in the next 6 months.  Full Article

Jiangxi Boya Bio-Pharmaceutical obtains high-tech enterprise recognition
Wednesday, 8 Mar 2017 04:20am EST 

Jiangxi Boya Bio-Pharmaceutical Co Ltd <300294.SZ> : Says it recognized as high-tech enterprise .Says it can enjoy tax preference of 15 percent for three years from Nov. 15, 2016.  Full Article

Jiangxi Boya Bio-pharma's shareholder uses 3.6 pct of share capital as collateral
Sunday, 19 Feb 2017 11:06am EST 

Jiangxi Boya Bio-Pharmaceutical Co Ltd <300294.SZ> :Says controlling shareholder uses 3.6 pct of issued share capital as collateral.  Full Article

Jiangxi Boya Bio-pharmaceutical expects Q1 to Q3 2016 net profit to increase by 60 to 90 pct
Wednesday, 12 Oct 2016 01:31am EDT 

Jiangxi Boya Bio-pharmaceutical Co Ltd <300294.SZ>: Says net profit for Q1 to Q3 of 2016 expected to increase by 60 percent to 90 percent, or to be 166.9 million to 198.2 million yuan .Says the net profit of Q1 to Q3 of 2015 was 104.3 million yuan.  Full Article

More From Around the Web